Update on the Kidney in HIV Treatment and Prevention: Current Concepts
Christina M. Wyatt, MD
Associate Professor of Medicine, Department of Nephrology
Icahn School of Medicine at Mount Sinai, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2014. All rights reserved.
Dr. Wyatt is actively involved in clinical care and clinical research in HIV-related kidney disease. Her research has focused on defining the epidemiology of kidney disease among HIV-infected individuals, including those with comorbid risk factors such as Hepatitis C co-infection and diabetes. She has established collaborations with several large HIV cohorts, and is the director of the clinical core of a longstanding P01 investigating the pathogenesis of HIV-associated nephropathy. She is also the PI of an R01 evaluating the renal safety of oral pre-exposure prophylaxis to prevent HIV infection.
At the completion of this educational session, learners will:
- Identify HIV-infected individuals who are at higher risk for acute and chronic kidney disease or ART nephrotoxicity.
- Understand the risk of nephrotoxicity and approaches to diagnosis and management in adults initiating therapy with TDF-containing ART or PrEP.
- Describe recent advances in nephrology and ART that may impact the management of HIV-infected individuals with kidney disease.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.
